Back to 
Pathstone Holdings, LLC
Pathstone Holdings, LLC
XERS
Showing 0 of 2 quarters
Position history for Pathstone Holdings, LLC's holdings in XERIS BIOPHARMA HOLDINGS INC
No. Pathstone Holdings exited its XERS (Xeris Biopharma Holdings) position in Q2 2024. Its Q1 2024 13F listed 18,098 shares worth $39,997. Pathstone Holdings first reported XERS in Q1 2024 and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.